JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M400930200 on May 4, 2004

J. Biol. Chem., Vol. 279, Issue 28, 29085-29091, July 9, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/28/29085    most recent
M400930200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Binet, V.
Right arrow Articles by Prézeau, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binet, V.
Right arrow Articles by Prézeau, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB Receptor*

Virginie Binet{ddagger}, Carole Brajon{ddagger}, Laurent Le Corre§, Francine Acher§, Jean-Philippe Pin{ddagger}, and Laurent Prézeau{ddagger}

From the {ddagger}Department of Molecular Pharmacology, Laboratory of Functional Genomic, CNRS UPR2580, Centre CNRS-INSERM de Pharmacologie et Endocrinologie, Montpellier 34094 cedex 5, France and §Laboratory of Pharmacological and Toxicological Chemistry and Biochemistry, UMR8601-CNRS, University René Descartes-Paris V, Paris 75270 cedex 6, France

The {gamma}-aminobutyric acid, type B (GABAB) receptor is well recognized as being composed of two subunits, GABAB1 and GABAB2. Both subunits share structural homology with other class-III G-protein-coupled receptors. They are composed of two main domains: a heptahelical domain (HD) typical of all G-protein-coupled receptors and a large extracellular domain (ECD). Although GABAB1 binds GABA, GABAB2 is required for GABAB1 to reach the cell surface. However, it is still not demonstrated whether the association of these two subunits is always required for function in the brain. Indeed, GABAB2 plays a major role in the coupling of the heteromer to G-proteins, such that it is possible that GABAB2 can transmit a signal in the absence of GABAB1. Today only ligands interacting with GABAB1 ECD have been identified. Thus, the compounds acting exclusively on the GABAB2 subunit will be helpful in analyzing the specific role of this subunit in the brain. Here, we explored the mechanism of action of CGP7930, a compound described as a positive allosteric regulator of the GABAB receptor. We showed that it activates the wild type GABAB receptor but with a low efficacy. The GABAB2 HD is necessary for this effect, although one cannot exclude that CGP7930 could also bind to GABAB1. Of interest, CGP7930 could activate GABAB2 expressed alone and is the first described agonistof GABAB2. Finally, we show that CGP7930 retains its agonist activity on a GABAB2 subunit deleted of its ECD. This demonstrates that the HD of GABAB2 behaves similar to a rhodopsin-like receptor, because it can reach the cell surface alone, can couple to G-protein, and be activated by agonists. These data open new strategies for studying the mechanism of activation of GABAB receptor and examine any possible role of homomeric GABAB2 receptors.


Received for publication, January 28, 2004 , and in revised form, May 4, 2004.

* This work was supported in part by grants from the CNRS, the Action Incitative "Molécules et Cibles Thérapeutiques" from INSERM, CNRS and the French government (to J.-P. P.), and by Addex Pharmaceuticals (Geneva, Switzerland). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Molecular Pharmacology, Laboratory for Functional Genomic, CNRS UPR-2580, 141 rue de la Cardonille, F-34094 Montpellier Cedex 5, France. Tel.: 33-467-14-2933; Fax: 33-467-54-2432; E-mail: lprezeau{at}ccipe.cnrs.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. Binet, B. Duthey, J. Lecaillon, C. Vol, J. Quoyer, G. Labesse, J.-P. Pin, and L. Prezeau
Common Structural Requirements for Heptahelical Domain Function in Class A and Class C G Protein-coupled Receptors
J. Biol. Chem., April 20, 2007; 282(16): 12154 - 12163.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. B. Knudsen, D. Kiel, M. Teng, C. Behrens, D. Bhumralkar, J. T. Kodra, J. J. Holst, C. B. Jeppesen, M. D. Johnson, J. C. de Jong, et al.
From the Cover: Small-molecule agonists for the glucagon-like peptide 1 receptor
PNAS, January 16, 2007; 104(3): 937 - 942.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. S. Dupuis, D. Relkovic, L. Lhuillier, J. Mosbacher, and K. Kaupmann
Point Mutations in the Transmembrane Region of GABAB2 Facilitate Activation by the Positive Modulator N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the Absence of the GABAB1 Subunit
Mol. Pharmacol., December 1, 2006; 70(6): 2027 - 2036.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Mukherjee, E. W. McBride, M. Beinborn, K. Dunlap, and A. S. Kopin
Point Mutations in Either Subunit of the GABAB Receptor Confer Constitutive Activity to the Heterodimer
Mol. Pharmacol., October 1, 2006; 70(4): 1406 - 1413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Rondard, J. Liu, S. Huang, F. Malhaire, C. Vol, A. Pinault, G. Labesse, and J.-P. Pin
Coupling of Agonist Binding to Effector Domain Activation in Metabotropic Glutamate-like Receptors
J. Biol. Chem., August 25, 2006; 281(34): 24653 - 24661.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Chen, N. Menendez-Roche, and E. Sher
Differential Modulation by the GABAB Receptor Allosteric Potentiator 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) of Synaptic Transmission in the Rat Hippocampal CA1 Area
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1170 - 1177.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Mitsukawa, R. Yamamoto, S. Ofner, J. Nozulak, O. Pescott, S. Lukic, N. Stoehr, C. Mombereau, R. Kuhn, K. H. McAllister, et al.
From The Cover: A selective metabotropic glutamate receptor 7 agonist: Activation of receptor signaling via an allosteric site modulates stress parameters in vivo
PNAS, December 20, 2005; 102(51): 18712 - 18717.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Ray, J. Tisdale, R. H. Dodd, P. Dauban, M. Ruat, and J. K. Northup
Calindol, a Positive Allosteric Modulator of the Human Ca2+ Receptor, Activates an Extracellular Ligand-binding Domain-deleted Rhodopsin-like Seven-transmembrane Structure in the Absence of Ca2+
J. Biol. Chem., November 4, 2005; 280(44): 37013 - 37020.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Jiang, M. Cui, B. Zhao, L. A. Snyder, L. M. J. Benard, R. Osman, M. Max, and R. F. Margolskee
Identification of the Cyclamate Interaction Site within the Transmembrane Domain of the Human Sweet Taste Receptor Subunit T1R3
J. Biol. Chem., October 7, 2005; 280(40): 34296 - 34305.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. Holst, E. Brandt, A. Bach, A. Heding, and T. W. Schwartz
Nonpeptide and Peptide Growth Hormone Secretagogues Act Both as Ghrelin Receptor Agonist and as Positive or Negative Allosteric Modulators of Ghrelin Signaling
Mol. Endocrinol., September 1, 2005; 19(9): 2400 - 2411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Goudet, J. Kniazeff, V. Hlavackova, F. Malhaire, D. Maurel, F. Acher, J. Blahos, L. Prezeau, and J.-P. Pin
Asymmetric Functioning of Dimeric Metabotropic Glutamate Receptors Disclosed by Positive Allosteric Modulators
J. Biol. Chem., July 1, 2005; 280(26): 24380 - 24385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Jiang, M. Cui, B. Zhao, Z. Liu, L. A. Snyder, L. M. J. Benard, R. Osman, R. F. Margolskee, and M. Max
Lactisole Interacts with the Transmembrane Domains of Human T1R3 to Inhibit Sweet Taste
J. Biol. Chem., April 15, 2005; 280(15): 15238 - 15246.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.